共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R029994-5mg | 5mg | 5~7个工作日 |
(5S,8S,10aR)-N-(二苯基甲基)十氢-5-[... AT406 (SM-406) |
99% |
|
|
阿拉丁 | A126412-5mg | 5mg | 现货 |
AT406 (SM-406) AT406 (SM-406) |
Moligand™, ≥98% |
|
|
阿拉丁 | A126412-10mg | 10mg | 现货 |
AT406 (SM-406) AT406 (SM-406) |
Moligand™, ≥98% |
|
|
阿拉丁 | A126412-50mg | 50mg | 现货 |
AT406 (SM-406) AT406 (SM-406) |
Moligand™, ≥98% |
|
|
阿拉丁 | A126412-25mg | 25mg | 现货 |
AT406 (SM-406) AT406 (SM-406) |
Moligand™, ≥98% |
|
|
阿拉丁 | A126412-100mg | 100mg | 现货 |
AT406 (SM-406) AT406 (SM-406) |
Moligand™, ≥98% |
|
|
阿拉丁 | X409188-1ml | 1ml | 现货 |
Xevinapant (AT406) Xevinapant (AT406) |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ008XJ2-10mg | 10mg | 期货,请咨询 |
SM 406; (5S,8S,10aR)-N-(二苯基甲... AT-406(AT406) |
98% |
|
|
凯为 | JZ008XJ2-25mg | 25mg | 期货,请咨询 |
SM 406; (5S,8S,10aR)-N-(二苯基甲... AT-406(AT406) |
98% |
|
|
凯为 | JZ008XJ2-50mg | 50mg | 期货,请咨询 |
SM 406; (5S,8S,10aR)-N-(二苯基甲... AT-406(AT406) |
98% |
|
|
毕得 | BD305467-10mg | 10mg | 现货 |
(5S,8S,10aR)-N-二苯甲基-5-((S)-2... (5S,8S,10aR)-N-Benzhydryl-5-... |
98% |
|
|
毕得 | BD305467-25mg | 25mg | 现货 |
(5S,8S,10aR)-N-二苯甲基-5-((S)-2... (5S,8S,10aR)-N-Benzhydryl-5-... |
98% |
|
|
毕得 | BD305467-50mg | 50mg | 现货 |
(5S,8S,10aR)-N-二苯甲基-5-((S)-2... (5S,8S,10aR)-N-Benzhydryl-5-... |
98% |
|
|
百灵威 | JK1564197-5MG | 5MG | 1天 |
AT 406拮抗剂 AT 406, 98%, a potent and or... |
98% |
|
|
百灵威 | JK934734-10MG | 10MG | 35天 |
化合物AT406 Xevinapant, 98% |
98% |
|
|
百灵威 | JK934734-5MG | 5MG | 35天 |
化合物AT406 Xevinapant, 98% |
98% |
|
|
百灵威 | JK934734-25MG | 25MG | 35天 |
化合物AT406 Xevinapant, 98% |
98% |
|
|
Matrix | MA143800-100mg | 100mg | 3-4周 |
(5S,8S,10aR)-N-benzhydryl-5-... (5S,8S,10aR)-N-benzhydryl-5-... |
95% | 咨询 | 请联系客服购买! |
Matrix | MA143800-1g | 1g | 3-4周 |
(5S,8S,10aR)-N-benzhydryl-5-... (5S,8S,10aR)-N-benzhydryl-5-... |
95% | 咨询 | 请联系客服购买! |
源叶 | S81198-5mg | 5mg | 现货 |
AT406 (SM-406) AT406 (SM-406) |
98% |
|
|
源叶 | S81198-10mg | 10mg | 现货 |
AT406 (SM-406) AT406 (SM-406) |
98% |
|
|
源叶 | S81198-25mg | 25mg | 现货 |
AT406 (SM-406) AT406 (SM-406) |
98% |
|
|
源叶 | T93051-1ml | 1ml | 期货,请咨询 |
Xevinapant (AT406) Xevinapant (AT406) |
10mM in DMSO |
|
|
Target Mol | T6763-1mg | 1mg | 现货 |
化合物 AT406 Xevinapant |
99.56% |
|
|
Target Mol | T6763-2mg | 2mg | 现货 |
化合物 AT406 Xevinapant |
99.56% |
|
|
Target Mol | T6763-5mg | 5mg | 现货 |
化合物 AT406 Xevinapant |
99.56% |
|
|
Target Mol | T6763-10mg | 10mg | 现货 |
化合物 AT406 Xevinapant |
99.56% |
|
|
Target Mol | T6763-25mg | 25mg | 现货 |
化合物 AT406 Xevinapant |
99.56% |
|
|
Target Mol | T6763-50mg | 50mg | 现货 |
化合物 AT406 Xevinapant |
99.56% |
|
|
Target Mol | T6763-100mg | 100mg | 现货 |
化合物 AT406 Xevinapant |
99.56% |
|
|
Target Mol | T6763-200mg | 200mg | 现货 |
化合物 AT406 Xevinapant |
99.56% |
|
|
Target Mol | T6763-1mL | 1mL | 现货 |
化合物 AT406 Xevinapant |
99.56% |
|
|
Target Mol | T6763-500mg | 500mg | 现货 |
化合物 AT406 Xevinapant |
99.56% |
|
|
Am | A780789-25mg | 25mg | 现货 |
Xevinapant Xevinapant |
98% |
|
|
Am | A780789-10mg | 10mg | 现货 |
Xevinapant Xevinapant |
98% |
|
|
Am | A780789-50mg | 50mg | 现货 |
Xevinapant Xevinapant |
98% |
|
|
Am | A780789-5mg | 5mg | 现货 |
Xevinapant Xevinapant |
98% |
|
|
Am | A780789-1mg | 1mg | 现货 |
Xevinapant Xevinapant |
98% |
|
|
MCE | HY-15454-50mg | 50mg | 现货 |
Xevinapant Xevinapant |
99.94% |
|
|
MCE | HY-15454-25mg | 25mg | 现货 |
Xevinapant Xevinapant |
99.94% |
|
|
MCE | HY-15454-10mM*1mL | 10mM*1mL | 现货 |
Xevinapant Xevinapant |
99.94% |
|
|
MCE | HY-15454-10mg | 10mg | 现货 |
Xevinapant Xevinapant |
99.94% |
|
|
MCE | HY-15454-5mg | 5mg | 现货 |
Xevinapant Xevinapant |
99.94% |
|
|
MCE | HY-15454-1mg | 1mg | 现货 |
Xevinapant Xevinapant |
99.94% |
|
|